Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Cost of Goods Sold | $0 | $1 | $0 | $0 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $0 | $0 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 27.1% | -29% | 22.9% | 21.4% |
| Other Income/Exp. Net | -$0 | $1 | -$0 | -$0 |
| Pre-Tax Income | $0 | $1 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS | 0.21 | 0.64 | 0.26 | 0.042 |
| % Growth | -67.2% | 146.2% | 513.2% | – |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $0 | $0 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |